Phreesia announced its Q3 Fiscal Year 2025 results, with total revenue up 17% year-over-year. The company narrowed its revenue outlook for fiscal 2025 to a range of $418 million to $420 million and updated its Adjusted EBITDA outlook for fiscal 2025 to a range of $34 million to $36 million.
Total revenue was $106.8 million, up 17% year-over-year.
Average number of healthcare services clients (AHSCs) was 4,237, up 15% year-over-year.
Net loss decreased to $14.4 million compared to $31.9 million in the same period of the prior year.
Adjusted EBITDA was $9.8 million compared to negative $6.6 million in the same period in the prior year.
The company is narrowing its revenue outlook for fiscal 2025 to a range of $418 million to $420 million, implying year-over-year growth of 17% to 18%. It is updating its Adjusted EBITDA outlook for fiscal 2025 to a range of $34 million to $36 million.
Visualization of income flow from segment revenue to net income